This is an application for the renewal of the R01 grant AI52731 'Innate NKT Cells in HIV Infection' which received a priority score of 136 with a 2.3 percentile, and was first funded in 2002. CDId-restricted natural killer T (NKT) cells are innate immune cells with key immunoregulatory functions. They directly recognize and respond to lipid antigens of bacterial origin and take active part in immune responses against such pathogens. Our studies have shown that the NKT cell compartment is severely compromised by HIV-1 infection, but can be partially restored by treatment with interleukin-2 (IL-2) therapy. In the first specific we will ascertain whether treatment of HIV-1 infected subjects with antiretroviral therapy in combination with IL-2 can induce sustained increases in circulating NKT cell frequency and functions.
We aim to determine the circulating NKT cell frequencies, surface phenotypes, and ex vivo effector functions longitudinally in subjects treated with ART alone or ART in combination with IL-2.
In specific aim 2 we will determine the mechanisms and consequences of CD1d down-regulation in HIV-1 infected dendritic cells.
We aim to determine the mechanism of HIV-1 interference with CD1-mediated antigen presentation, and to investigate the functional consequences of this for NKT cell recognition of glycolipid antigens, and the downstream activation of both the DC and NK cells.
In specific aim 3 we will investigate the relationship between NKT cell loss in HIV-1 infected subjects and the emergence of mycobacterial infections. Our preliminary data suggests that control of Mycobacterium tuberculosis is impaired in HIV-1-uninfected subjects with low levels of circulating NKT cells. We will compare NKT cell frequencies in HIV-1 infected subjects with MTB with age and CD4 T cell count matched controls to determine whether MTB is associated with lower NKT cell frequencies. We will also test whether treatment of MTB is associated with increases in NKT cells to assess whether lower NKT cell counts may be an underlying risk factor for MTB or may represent a sequelae of untreated MTB. We believe that the continued studies we propose will contribute considerably to our understanding of how NKT cells function in HIV-1 disease, how the virus attempts to escape NKT cell activation, and how they may contribute to the innate defense against HIV-1 infection and AIDS-defining opportunistic infections.
|Leeansyah, Edwin; Loh, Liyen; Nixon, Douglas F et al. (2014) Acquisition of innate-like microbial reactivity in mucosal tissues during human fetal MAIT-cell development. Nat Commun 5:3143|
|Andersson, Sofia K; Paquin-Proulx, Dominic; Kroll, Mirko et al. (2013) Technical advance. Measurement of iNKT cell responses at the single-cell level against rare HIV-1-infected dendritic cells in a mixed culture. J Leukoc Biol 93:449-55|
|Paquin-Proulx, Dominic; Santos, Bianca A N; Carvalho, Karina I et al. (2013) Dysregulated CD1 profile in myeloid dendritic cells in CVID is normalized by IVIg treatment. Blood 121:4963-4|
|Flach, Britta; Naluyima, Prossy; Blom, Kim et al. (2013) Differential loss of invariant natural killer T cells and FoxP3? regulatory T cells in HIV-1 subtype A and subtype D infections. J Acquir Immune Defic Syndr 63:289-93|
|Tjomsland, Veronica; Ellegard, Rada; Kjolhede, Preben et al. (2013) Blocking of integrins inhibits HIV-1 infection of human cervical mucosa immune cells with free and complement-opsonized virions. Eur J Immunol 43:2361-72|
|Futalan, Diahnn; Huang, Chien-Tze; Schmidt-Wolf, Ingo G H et al. (2011) Effect of oxygen levels on the physiology of dendritic cells: implications for adoptive cell therapy. Mol Med 17:910-6|
|Tjomsland, Veronica; Ellegard, Rada; Che, Karlhans et al. (2011) Complement opsonization of HIV-1 enhances the uptake by dendritic cells and involves the endocytic lectin and integrin receptor families. PLoS One 6:e23542|
|Kuylenstierna, Carlotta; Bjorkstrom, Niklas K; Andersson, Sofia K et al. (2011) NKG2D performs two functions in invariant NKT cells: direct TCR-independent activation of NK-like cytolysis and co-stimulation of activation by CD1d. Eur J Immunol 41:1913-23|
|Kuylenstierna, C; Snyder-Cappione, J E; Loo, C P et al. (2011) NK cells and CD1d-restricted NKT cells respond in different ways with divergent kinetics to IL-2 treatment in primary HIV-1 infection. Scand J Immunol 73:141-6|
|Tjomsland, Vegard; Spangeus, Anna; Sandstrom, Per et al. (2010) Semi mature blood dendritic cells exist in patients with ductal pancreatic adenocarcinoma owing to inflammatory factors released from the tumor. PLoS One 5:e13441|
Showing the most recent 10 out of 23 publications